Express registration and login! If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.
VIENNA, AUSTRIA (UroToday.com) - The chromophobe subtype is associated with a better prognosis compared with the clear cell subtype. This is true for non-metastatic as well as metastatic tumors.
VIENNA, AUSTRIA (UroToday.com) - Cytoreductive nephrectomy should be performed in patients with metastatic kidney cancer who are fit enough for surgery.
VIENNA, AUSTRIA (UroToday.com) - Unfortunately most series on open nephrectomy and partial nephrectomy as well as laparoscopic nephrectomy and partial nephrectomy are non-randomized and retrospective.
VIENNA, AUSTRIA (UroToday.com) - Partial nephrectomy for T1b tumors is most often performed in an open manner rather than with minimally invasive techniques.
VIENNA, AUSTRIA (UroToday.com) - The knowledge of histological subtypes of kidney cancer and their specific biological behavior has been an important step forward.
VIENNA, AUSTRIA (UroToday.com) - Prognostic systems to predict outcome of non-metastatic kidney cancer could have impact of possible adjuvant therapy and/or follow-up strategies.
VIENNA, AUSTRIA (UroToday.com) - In the past 10 years four major prognostic systems had been published to predict outcome of non-metastatic kidney cancer: the Kattan nomogram, the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN), the University of Los Angeles Integrated Staging System (UISS) and the Karakiewicz nomogram.